NCLH vs ROIV · P/E 16, rev $4.97B vs rev $8.3M
Norwegian Cruise Line Holdings Ltd (NCLH) versus Roivant Sciences Ltd (ROIV) — a side-by-side from cached financials, not a winner call.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 71.6% from 2025-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
NCLH currently screens at market cap $9.10B and trailing P/E 16.0. ROIV currently screens at market cap $7.47B.
Not investment advice. Open the NCLH and ROIV stock pages for the full models.
Not investment advice.